Effects of Safflower seed oil in osteoporosis induced-ovariectomized rats

American Journal of Chinese Medicine

Volumn 34, Issue 4, 2006, Pages 601-612

  Alam, Md Rafiqul ^a   Kim, Soo Mi ^a   Lee, Jong Il ^a   Chon, Seung Ki ^a   Choi, Sung Jin ^a   Choi, In Hyuk ^a   Kim, Nam Soo ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Bone alkaline phosphatase; IGBP 3; IGF I, IGF II; Ovariectomy; Safflower seed

Indexed keywords

ALKALINE PHOSPHATASE; ALKALINE PHOSPHATASE BONE ISOENZYME; BROMINE; CALCIUM; CHLORINE; CHROMIUM; COBALT; COPPER; ESTROGEN; IRON; PHOSPHORUS; SAFFLOWER OIL; SCANDIUM; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; ESTROGEN BLOOD LEVEL; FEMALE; FEMUR; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSTEOPOROSIS; OVARIECTOMY; PHOSPHATE BLOOD LEVEL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; RANDOMIZATION; RAT; SAFFLOWER; STATISTICAL SIGNIFICANCE; TIBIA;

ADMINISTRATION, ORAL; ALKALINE PHOSPHATASE; ANIMALS; CALCIUM; ESTROGENS; FEMALE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOPOROSIS; OVARIECTOMY; PHOSPHORUS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SAFFLOWER OIL;

EID: 33749482970     PISSN: 0192415X     EISSN: None     Source Type: Journal    
DOI: 10.1142/S0192415X06004132     Document Type: Article

References (29)

1. Baldock P.A.J., H.A. Morris, R.J. Moore and A.G. Need. Prepubertal oophorectomy limits the accumulation of cancellous bone in the femur of growing rats with long-term effects on metaphyseal bone architecture. Calcif. Tissue Int. 62: 244-249, 1998.
2. Barengolts, E.I., T. Kouznetsova, A. Segalene, P. Lathon and C. Odvina. Effects of progesterone on serum levels of IGF-I and femur IGF-I mRNA in ovariectomized rats. J. Bone Miner. Res. 11: 1406-1412, 1996.
3. Clark, R.G., D. Mortensen, D. Reifsynder, M. Mohler, T. Etcheverry and V. Mukku. Recombinant human insulin-like.growth factor binding protein-3 (rhIGFBP-3): Effects on the glycemic and growth promoting activities of rhIGF-1 in the rat. Growth Regul. 350-352, 1993.
4. Danielsen, C.C. and A. Flyvbjerg. Insulin-like growth factor-I as a predictor of cortical bone mass in a long-term study of ovariectomized and estrogen-treated rats. Bone 19: 493-498, 1996.
5. Daughaday, W.H., B. Trivedi and M. Kapadia. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. J. Clin. Endocrinol. Metabol. 53: 289-294, 1981.
6. Dick, I.M., A.S. John, S. Heal and R.L. Prince. The effect of estrogen deficiency on bone mineral density, renal calcium and phosphorus handling and calcitropic hormones in the rat. Calcif. Tissue Int. 59: 174-178, 1996.
7. Draper, C.R., M.J. Edel, I.M. Dick, A.G. Randall, G.B. Martin and R.L. Prince. Phytoestrogens reduce bone loss and bone resorption in oophorectomized rats. J. Nutr. 127: 1795-1799, 1997.
8. Frost, H.M. and W.S.S. Jee. On the rat model of human osteopenias and osteoporosis. Bone Miner. 18: 227-236, 1992.
9. Guler, H.P., J. Zapf, E. Scheiwiller and E.R. Froesch. Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc. Natl. Acad. Sci. 85: 4889-4893, 1988.
10. Hill, P.A., J.J. Reynolds and M.C. Meikle. Osteoblasts mediate insulin-like growth factor-I and -II stimulation of osteoclast formation and function. Endocrinology 136: 124-131, 1995.
11. Hwan, O.J. and Y.S. Lee. Effects of dietary calcium levels on the reduction calcium availability in ovariectomized osteoporosis model rats. Korean J. Nutr. 26: 277-285, 1993.
12. Jones, I.J. and D.R. Clemmons. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16: 3-34, 1995.
13. Kalu, D.N. The ovariectomized rat model of postmenopausal bone loss. Bone Miner. 15: 175-191, 1991.
14. Kalu, D.N., B.H. Arjmandi, C.C. Liu, M.A. Salih and R.S. Birnbaum. Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3. Bone Miner. 25: 135-148, 1994.
15. Kang, G.H., E.J. Chang and S.W. Choi. Antioxidative activity of phenolic compounds in roasted safflower (Carthamus tinctorius L.) seeds. J. Food Sci. Nutr. 4: 221-225, 1999.
16. Kassem, M., K. Brixen, W. Blum, L. Mosekilde, E.F. Eriksen. No evidence for reduced spontaneous or growth-hormone-stimulated serum levels of insulin-like growth factor (IGF)-I, IGF-II or IGF binding protein 3 in women with spinal osteoporosis. Eur. J. Endocrinol. 131: 150-155, 1994.
17. Kawakami, A., T. Nakashima, M. Tsuboi, S. Urayama, N. Matsuoka, H. Ida, Y. Kawabe, H. Sakai, K. Migita, T. Aoyagi, M. Nakashima, K. Maeda and K. Eguchi. Insulin-like growth factor I stimulates proliferation and Fas-mediated apoptosis of human osteoblasts. Biochem. Biophys. Res. Commun. 247: 46-51, 1998.
18. Kim, H.J., Y.C. Bae, R.W. Park, S.W. Choi, S.H. Cho, Y.S. Choi and W.J. Lee. Bone-protecting effect of safflower seeds in ovariectomized rats. Calcif. Tissue Int. 71: 88-94, 2002a.
19. Kim, H.Y., C.S. Kim, G.J. Jhon, I.S. Moon, S.H. Choi, K.S. Cho, J.K. Chai and C.K. Kim. The effect of safflower seed extract on periodontal healing of 1-wall intrabony defects in beagle dogs. J. Periodontol. 73: 1457-1466, 2002b.
20. Machwate, M., E. Zerath, X. Holy, P. Pastoureau and P.J. Marie. Insulin-like growth factor-I increases trabecular bone formation and osteoblastic cell proliferation in unloaded rats. Endocrinology 134: 1031-1038, 1994.
21. Nasu, M., T. Sugimoto, M. Chihara, M. Hiraumi, F. Kurimoto and K. Chihara. Effect of natural menopause on serum levels of IGF-I and IGF-binding proteins: Relationship with bone mineral density and lipid metabolism in perimenopausal women. Eur. J. Endocrinol. 136: 608-616, 1997.
22. Qin, X., D. Byun, D.D. Strong, D.J. Baylink and S. Mohan. Studies on the role of human insulin-like growth factor-II (IGF-II)-dependent IGF binding protein (hIGFBP)-4 protease in human osteoblasts using protease-resistant IGFBP-4 analogs. J. Bone Miner. Res. 14: 2079-2088, 1999.
23. Ravn, P., K. Overgaard, E.M. Spencer and C. Christiansen. Insulin-like growth factors I and II in healthy women with and without established osteoporosis. Eur. J. Endocrinol. 132: 313-319, 1995.
24. Rosen, C.J. and M. Pollak. Circulating IGF-I: New perspectives for a new century. Trends Endocrinol. Metab. 10: 136-141, 1999.
25. Schmid, C., C. Keller, I. Schlapfer, C. Veldman and J. Zapf. Calcium and insulin-like growth factor I stimulation of sodium-dependent phosphate transport and proliferation of cultured rat osteoblasts. Biochem. Biophys. Res. Commun. 245: 220-225, 1998.
26. Seo, H.J., H.J. Kim, D.Y. Kwak, S.M. Jeon, S.K. Ku, J.H. Lee, K.D. Moon and M.S. Choi. The effects of safflower seed powder and its fraction on bone tissue in rib-fracture rats during recovery. Korean J. Nutr. 33: 411-420, 2000.
27. Stewart, C.E.H. and P. Rotwein. Growth, differentiation and survival: Multiple physiological functions for insuline-like growth factors. Physiol. Rev. 76: 1005-1026, 1996.
28. Stewart, C.H., D.C. Bates, T.A. Calder, S. Woodall and I.M. Pell. Potentiation of insulin-like growth factor (IGF-I) activity by an antibody supportive evidence for enhancement of IGF-I bioavailability in vivo by IGF binding proteins. Endocrinology 133: 1462-1465, 1993.
29. Van Straalen, J.P., E. Sanders, M.F. Prummel and G.T. Sanders. Bone-alkaline phosphatase as indicator of bone formation. Clinica. Chimica Acta 201: 27-33, 1991.